EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid Droplet‐Organized MDM2‐Mediated P53 Degradation: A Metabolic Switch Governing Diet‐Driven Tumor Progression

Haiyang Liu iD, Lin Jing, Yixin Li, Jinxing Zhou, Xiaohui Cui, Sen Li, Shijie Yang, Fangming Kan, Junfeng Du, Wentao Zhong, Sheng Yu, Ning Wang und 9 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202503473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Haiyang Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Lipid Droplets, Diet, High-Fat, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation of China, National Natural Science Foundation of China, Major Program of Nanozyme Laboratory in Zhongyuan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TP53 inactivation in human cancers often results from MDM2/MDMX overexpression, yet therapeutic targeting remains challenging owing to incomplete mechanistic understanding. Lipid droplet (LD) enrichment is identified as a key trigger for MDM2‐mediated p53 degradation. High‐fat diet (HFD)‐induced LD accumulation in tumor cells elevates LD‐surface MDM2 through Cyb5r3‐Myh9 interactions, which recruit cytoplasmic p53/Myh9 complexes to LDs. This spatial proximity enhances MDM2‐p53 binding, accelerating its ubiquitination and proteasomal degradation. Degraded p53 releases the RPS3A‐C/EBPβ complex, upregulating LD‐promoting factors such as CD36 to establish a cell‐autonomous feed‐forward loop. Critically, pharmacological LD reduction (via lipogenesis inhibitors) or switching of tumor‐bearing mice from an HFD to a normal diet restores p53 levels and suppresses tumor growth. These findings delineate a lipid‐driven regulatory axis in which LD biogenesis initiates MDM2‐dependent p53 destruction, reshaping tumor cell lipid metabolism. This mechanism links dietary lipids to oncogenesis through organelle‐specific protein trafficking and provides a therapeutic rationale for targeting lipid metabolism in tumors. This study resolves critical gaps in p53 regulation while proposing dual intervention strategies: disrupting LD‐MDM2 colocalization and modulating lipid availability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Lipid DropletsDiet, High-FatNeoplasmsTumor Suppressor Protein p53HumansDisease ProgressionHypertriglyceridemiaFemaleAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

high‐fat dietslipid dropletsp53 degradation initiationtumor growth

Substanzen

Tumor Suppressor Protein p53Proto-Oncogene Proteins c-mdm2

Autor:innen und Institutionen

  • Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Research Institute of Pancreatic Diseases, Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • State Key Laboratory of Systems Medicine for Cancer, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200025, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, PR China.
  • Nanozyme Laboratory in Zhongyuan, Henan Academy of Innovations in Medical Science, Zhengzhou, 451163, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

ORCID-Profile: Haiyang Liu

Förderung

  • Beijing Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Major Program of Nanozyme Laboratory in Zhongyuan

Zitieren

APA

Liu, H., Jing, L., Li, Y., Zhou, J., Cui, X., Li, S., Yang, S., Kan, F., Du, J., Zhong, W., Yu, S., Wang, N., Jia, X., Li, J., Nie, P., Chen, Z., Han, Y., Jiang, L., Yan, X., …, & Shen, B. (2025). Lipid Droplet‐Organized MDM2‐Mediated P53 Degradation: A Metabolic Switch Governing Diet‐Driven Tumor Progression. Advanced Science. https://doi.org/10.1002/advs.202503473

Vancouver

Liu H, Jing L, Li Y, Zhou J, Cui X, Li S, et al. Lipid Droplet‐Organized MDM2‐Mediated P53 Degradation: A Metabolic Switch Governing Diet‐Driven Tumor Progression. Advanced Science. 2025. doi:10.1002/advs.202503473

BibTeX
@article{Liu2025,
  author = {Liu, Haiyang and Jing, Lin and Li, Yixin and Zhou, Jinxing and Cui, Xiaohui and Li, Sen and Yang, Shijie and Kan, Fangming and Du, Junfeng and Zhong, Wentao and Yu, Sheng and Wang, Ning and Jia, Xing and Li, Junhui and Nie, Pan and Chen, Zhenzhong and Han, Ying and Jiang, Lingxi and Yan, Xiyun and Duan, Hongxia and Shen, Baiyong},
  title = {Lipid Droplet‐Organized MDM2‐Mediated P53 Degradation: A Metabolic Switch Governing Diet‐Driven Tumor Progression},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503473}
}
Kostenlos starten →